Matches in Nanopublications for { ?s ?p "[Complex EGFR mutations are not rare. Gefitinib has different efficacy according to the type of complex EGFR mutations. Patients with Del-19 and L858R mutations may benefit more from gefitinib than other types of complex mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[Complex EGFR mutations are not rare. Gefitinib has different efficacy according to the type of complex EGFR mutations. Patients with Del-19 and L858R mutations may benefit more from gefitinib than other types of complex mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP184887.RAQE5gD13GKCerZVQ8Qa36n5ZdPv3gZRCMoE1SAboLjsU130_assertion description "[Complex EGFR mutations are not rare. Gefitinib has different efficacy according to the type of complex EGFR mutations. Patients with Del-19 and L858R mutations may benefit more from gefitinib than other types of complex mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184887.RAQE5gD13GKCerZVQ8Qa36n5ZdPv3gZRCMoE1SAboLjsU130_provenance.